|
????Sildenafil??????Vardenafil??????????????????ED????????????????????????????????????????????????
??????? ????Sildenafil??????????????????Sildenafil??????????-5?PDE5???????????????PDE5??????????????????????????????????????? ????Vardenafil??????????????????Vardenafil?????PDE5????????????????????PDE5?????????????????????????? ???????????? ????????????????????????????????????????????????????????PDE5??????????????????????? ??????????? 1.????????????????100????????????????????????????30???1??????????????????????????????????????? 2.????????????????20?????????????????????????????????????????????
???????????? 1.??????????????????????4-6????????????????????????????????????????????? 2.?????????????????????????????5-7??????????????????? ???????????? 1.?????????????????????????????????????????????????????????????????????????????????????? 2.?????????????????????????????????????????????????????????????????????????? ????????????????????ED?????????????????????????????????????????????????????????????????? ????? 1.Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., ... & Wespes, E. (2010). Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European urology, 57(5), 804-814. 2.Kloner, R. A., Jackson, G., Hutter Jr, A. M., & Mittleman, M. A. (2003). Cardiovascular safety update of tadalafil: retrospective analysis of data from placebo?controlled and open?label clinical trials of tadalafil with as needed, three times?per?week or once?a?day dosing. The American journal of cardiology, 92(9), 33-40. |
